On Wednesday, General Electric Company (NYSE:GE)’s shares inclined 0.31% to $28.87.
General Electric Company (GE) has beta value of 1.23. The company has the market capitalization of $290.58 billion. Return on assets ratio of the company was -1.20% while its return on equity ratio was -6.40%. ATR value of company was 0.58 while stock volatility for week was 2.16% while for month was 1.95%. Debt to equity ratio of the company was -2.47.
General Electric Company (GE) is a diversified infrastructure and financial services company. The products and services of the Company range from aircraft engines, power generation, oil and gas production equipment, and household appliances to medical imaging, business and consumer financing and industrial products.
eBay Inc (NASDAQ:EBAY)’s shares dropped -0.86% to $24.21.
eBay Inc (EBAY) offered -53.40% EPS for prior five years. The company has 12.20% return on equity value while its ROI ratio was 0.10%. The company has $29.75 billion market capitalizations and the institutional ownership was 83.20%. Its price to book ratio was 1.49. Volatility of the stock was 1.79% for the week while for the month booked as 2.47%.
eBay Inc.(eBay) is a global technology company. The Company has created an open source platform that provides software developers and merchants access to its applications programming interfaces (APIs), to develop software and solutions for commerce.
At the end of Wednesday’s trade, Abbott Laboratories (NYSE:ABT)‘s shares surged 1.08% to $42.20.
Abbott Laboratories (ABT) is currently valued at $62.21 billion. The company has 1.49 billion shares outstanding and 70.50% shares of the company were owned by institutional investors. The company has 3.07 value in price to sale ratio while price to book ratio was recorded as 2.74. The company exchanged hands with 8.90 million shares as compared to its average daily volume of 7.84 million shares. It beta stands at 0.83.
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a range of health care products. Abbott operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The Established Pharmaceutical Products segment comprises the international sales of a line of branded generic pharmaceutical products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
